Organisation typeRegistered Company
Collaborate statusWants to collaborate
About this entry
OmiX Labs is dedicated to developing low-cost devices and processes for diagnosing infectious diseases. Our initial products are to be based on nucleic acid testing (NAT) of pathogens from blood and urine samples. As NAT works on the principle of species identification (together with any significant mutations), our technology lends itself naturally to detecting anti-microbial resistant strains of pathogens.
The founders come with extensive experience in quantitative biomedical science, having led groups and carried out research at GE Healthcare, IBM Research, Harvard School of Public Health, Massachusetts Institute of Technology, and Stanford University. The team consists of molecular biologists and biotechnologists working on developing assays and establishing protocols.
OmiX Labs is based in Bengaluru (Bangalore) and has several collaborations including Indian Institute of Science, National Chemical Laboratory, and rural diagnostics centres in India. We are currently looking for financial support and technical expertise in building our first physical prototype.